SANES

10.662

-0.43%↓

BBVA

19.435

-0.87%↓

BNP

93.66

+0.01%↑

CABK

11.52

-0.04%↓

INGA

26.005

-1.12%↓

SANES

10.662

-0.43%↓

BBVA

19.435

-0.87%↓

BNP

93.66

+0.01%↑

CABK

11.52

-0.04%↓

INGA

26.005

-1.12%↓

SANES

10.662

-0.43%↓

BBVA

19.435

-0.87%↓

BNP

93.66

+0.01%↑

CABK

11.52

-0.04%↓

INGA

26.005

-1.12%↓

SANES

10.662

-0.43%↓

BBVA

19.435

-0.87%↓

BNP

93.66

+0.01%↑

CABK

11.52

-0.04%↓

INGA

26.005

-1.12%↓

SANES

10.662

-0.43%↓

BBVA

19.435

-0.87%↓

BNP

93.66

+0.01%↑

CABK

11.52

-0.04%↓

INGA

26.005

-1.12%↓

Home・Lista de Ações・Sartorius Stedim Biotech.

Sartorius Stedim Biotech.

Fechado

SetorFinanças

179.2 -2.08

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

179.1

Máximo

180.6

Indicadores-chave
By Trading Economics
Rendimento	41M 88M
Vendas	-11M 762M
P/E Médio do Setor	64.546 41.721
EPS	1.17
Margem de lucro	11.569
Funcionários	10,456
EBITDA	26M 225M

Recomendações
By TipRanks
Recomendações	Compra Forte
Previsão para 12 meses	+30.03% upside

Dividendos
By Dow Jones
Próximos Ganhos	23 de jul. de 2026

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	-897M 17B
Abertura anterior	181.28
Fecho anterior	179.2

Sentimento de Notícias

By Acuity

20%

80%

32 / 439 Ranking em Finance

Sartorius Stedim Biotech. Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

5 de jun. de 2026, 19:20 UTC

Grandes Movimentos do Mercado

Meta Platforms Slips on Report of Plans for Multibillion-Dollar Offering to Fund AI Buildout

6 de jun. de 2026, 08:20 UTC

Conversa de Mercado

Tech, Media & Telecom Roundup: Market Talk

6 de jun. de 2026, 08:20 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

6 de jun. de 2026, 04:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

6 de jun. de 2026, 00:14 UTC

Aquisições, Fusões, Aquisições de Empresas

4 Arm Execs Sold $26 Million in Stock, but They Missed a High -- Barrons.com

5 de jun. de 2026, 21:27 UTC

Ganhos

Carnage in Chip Stocks Hits Extra Hard in Top-Heavy Market -- WSJ

5 de jun. de 2026, 20:50 UTC

Conversa de Mercado

Tech, Media & Telecom Roundup: Market Talk

5 de jun. de 2026, 20:50 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

5 de jun. de 2026, 20:20 UTC

Aquisições, Fusões, Aquisições de Empresas

Altice France Group Had Granted Initial Exclusivity Period to Consortium Until May 15, Which Was Then Extended to June 5

5 de jun. de 2026, 20:19 UTC

Aquisições, Fusões, Aquisições de Empresas

Altice France Group, Bouygues Telecom, Free-iliad Group, Orange Exclusivity Period Extended by 48 Hours

5 de jun. de 2026, 20:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

5 de jun. de 2026, 19:26 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

5 de jun. de 2026, 19:26 UTC

Conversa de Mercado

Hog Futures Tumble to Close Week -- Market Talk

5 de jun. de 2026, 19:10 UTC

Conversa de Mercado

Canada's GDP Targets From AI-Related Spending Require Second Look -- Market Talk

5 de jun. de 2026, 19:03 UTC

Conversa de Mercado

Oil Falls As Market Holds Out Hope for End to Conflict -- Market Talk

5 de jun. de 2026, 18:59 UTC

Conversa de Mercado

U.S. Natural-Gas Futures Pull Back After Gains -- Market Talk

5 de jun. de 2026, 18:47 UTC

Conversa de Mercado

Canada's Labor Market 'Retains Some Weakness' Despite Stellar May Report -- Market Talk

5 de jun. de 2026, 18:34 UTC

Conversa de Mercado

Hyperliquid ETFs Have Inflows Despite Crypto Weakness -- Market Talk

5 de jun. de 2026, 18:33 UTC

Aquisições, Fusões, Aquisições de Empresas

The U.S. Government Could Take a Stake in OpenAI. What That Means for Tech Stocks. -- Barrons.com

5 de jun. de 2026, 17:50 UTC

Ganhos

Lululemon Slumps on Earnings. Bargain Hunters Beware. -- Barrons.com

5 de jun. de 2026, 17:27 UTC

Conversa de Mercado

U.S. Oil Rig Count Rises for 6th Straight Week -- Market Talk

5 de jun. de 2026, 16:48 UTC

Aquisições, Fusões, Aquisições de Empresas

Ryan Cohen Is Ready to Talk About eBay. For Real. -- Barrons.com

5 de jun. de 2026, 16:20 UTC

Conversa de Mercado

Tech, Media & Telecom Roundup: Market Talk

5 de jun. de 2026, 16:20 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

5 de jun. de 2026, 16:20 UTC

Conversa de Mercado

Health Care Roundup: Market Talk

5 de jun. de 2026, 16:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

5 de jun. de 2026, 15:44 UTC

Aquisições, Fusões, Aquisições de Empresas

Ryan Cohen Is Ready to Talk About eBay. For Real. -- Barrons.com

5 de jun. de 2026, 15:26 UTC

Conversa de Mercado

Gold Down Nearly 3% On Rate Hike Concerns After U.S. Hiring Data -- Market Talk

5 de jun. de 2026, 15:25 UTC

Ganhos

Quantinuum Trades Below Offer Price. Why the Quantum Stock Is Sliding. -- Barrons.com

5 de jun. de 2026, 15:16 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

Comparação entre Pares

Variação de preço

Sartorius Stedim Biotech. Previsão

Preço-alvo

By TipRanks

30.03% parte superior

Previsão para 12 meses

Média 232.63 EUR 30.03%

Máximo 262 EUR

Mínimo 210 EUR

Com base em 9 analistas de Wall Street que oferecem metas de preço de 12 meses para Sartorius Stedim Biotech. - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

9 ratings

Comprar

Manter

Vender

Com base em 9 analistas que deram avaliações de ações para Sartorius Stedim Biotech. - Dist nos últimos 3 meses.

Sentimento

By Acuity

32 / 439 Ranking em Finanças

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre Sartorius Stedim Biotech.

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; biolayer interferometry instruments; microbiology enumeration, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; biomolecule analysis tools; flow cytometry; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; and weighing products. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production; process automation platform and software; and develops and produces transfection, as well as other DNA/RNA delivery reagents and plasmid DNA. It serves manufacturers of medications, vaccines, foods, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. As of December 31, 2023, Sartorius Stedim Biotech S.A. operates as a subsidiary of Sartorius AG.